BILIARY TRACT CANCER
Clinical trials for BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple attack on tough bile duct cancer
Disease control Not yet recruitingThis study is testing a new three-drug combination for people with advanced bile duct cancer that has a specific marker called HER2. The goal is to see if the combination can shrink tumors and control the disease. About 65 participants will receive the treatment, and researchers …
Matched conditions: BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New targeted drug trial offers hope for Tough-to-Treat bile duct cancer
Disease control Not yet recruitingThis study is testing an experimental drug called SHR-A1904 for people with advanced bile duct cancer that has spread or cannot be removed by surgery and has stopped responding to standard treatments. The drug is designed to target cancer cells that have a specific marker called …
Matched conditions: BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Simple blood test could replace risky biopsies for bile duct cancer
Knowledge-focused Not yet recruitingThis study is testing whether a simple blood test can find specific genetic changes in advanced bile duct cancer, which is often hard to biopsy. Researchers will enroll 100 patients to see if the blood test results match traditional tissue tests and if they can help predict how w…
Matched conditions: BILIARY TRACT CANCER
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:51 UTC